Loading market dashboard
Danaher Corporation
DHRHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Pre-Market Stock Futures: Futures are trading lower on Tuesday, but the technology tsunami continued on Monday, as all major indices dipped into the red early on news that Iran was halting the peace negotiations and would block the Strait of Hormuz. But that sell-off lasted until about noon, before a big reversal, which, by that... Here Are Tuesday's Top Wall Street Analyst Research Calls: CoreWeave, Danaher, Hewlett Packard Enterprise, Intuit, Knight-Swift, Meta Platforms, Starwood Property Trust, Tripadvisor, and More
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #massspec--SCIEX advances the ZenoTOF line with platform-wide expansions in software, integrations, and key collaborations.
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #V55--SCIEX launches the novus V55 system with SCIEX OS 5.0 software and AI enablement tools.
On May 28, 2026, Danaher Corp (DHR) shares rose 4.3%, reflecting a positive shift in market sentiment. The stock is currently trading at $180.63, within a 52-we
Barron's Oil & Blue Chip Tips for May 2026 highlight 20 stocks, with 11 deemed 'safer' based on free cash flow yields exceeding dividend yields. Top ten by yield are projected to deliver average net gains of 36.08% by May 2027, with risk/volatility 24% below the market average. Zoetis (ZTS), Danaher (DHR), and Accenture (ACN) lead in projected returns, with ZTS estimated to net 60.33% and lower-than-market volatility.
Danaher (DHR) reported earnings 30 days ago. What's next for the stock?
DHR's Biotechnology segment posts 7% core revenue growth as bioprocessing demand stayed strong and equipment orders jumped despite headwinds.
Pre-Market Stock Futures: Futures are trading sharply lower as we get set to end one of the most exciting weeks on Wall Street in 25 years. Positive meetings in China with President Trump, who brought his CEO contingent and Elon Musk, and President Xi, massive upside earnings and forward guidance from an OG tech and... Here Are Friday's Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More
Danaher Corporation (DHR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
WASHINGTON, May 6, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 13, 2026 at 11:20 a.m.
WASHINGTON, May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to holders of record on June 26, 2026. ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the “Merger Agreement”), by and among Masimo, Danaher Corporation (“Danaher”) (NYSE: DHR) and Mobius Merger Sub, Inc. (the “Merger Sub”) at Masimo's special meeting of stockholders held virtually on May 1, 2026 (.
XYL tops Q1 estimates as Measurement & Control demand lifts results, while raising 2026 revenue outlook.
AEGON ASSET MANAGEMENT UK Plc lifted its stake in shares of Danaher Corporation (NYSE: DHR) by 81.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 328,147 shares of the conglomerate's stock after purchasing an additional 146,929 shares during the quarter. Danaher comprises
Calamos Advisors LLC boosted its holdings in Danaher Corporation (NYSE: DHR) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 243,698 shares of the conglomerate's stock after purchasing an additional 20,180 shares during the quarter. Calamos Advisors LLC's
This blue chip stock has been in a multiyear slump, but things are looking up.
Arizona State Retirement System decreased its position in shares of Danaher Corporation (NYSE: DHR) by 3.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 181,341 shares of the conglomerate's stock after selling 6,790 shares during the period. Arizona State Retirement System's
Danaher reached a $172.5 million settlement with shareholders who accused the diagnostics and life-sciences company of defrauding them by overstating demand for its equipment as the worst of the COVID-19 pandemic passed.
WASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): €500,000,000 principal amount of floating rate senior notes due 2028 at an offering price of 100.000% of the principal amount; €750,000,000 principal amount of 3.250% senior notes due 2030 at an offering price of 99.934% of the principal amount; €750,000,000 principal amount of 3.625% senior notes due 2034 at an offering price of 99.918% of the principal amount; and €1,000,000,000 principal amount of 4.000% senior notes due 2038 at an offering price of 99.953% of the principal amount (collectively, the "senior notes"). Danaher estimates that the net proceeds from the sale of the senior notes will be approximately €2.98 billion, after deducting the underwriting discounts and estimated offering expenses payable by Danaher.
Danaher had another somewhat uneventful quarter. Margin in biotechnology segment improved YoY to reach 42.7% in 1Q'26. Life Sciences segment's core revenue grew at only 0.5% despite having an easy comp of -4% in 1Q'25.
Danaher (NYSE: DHR) reported first-quarter 2026 sales of $6.0 billion, with core revenue up 0.5% year over year as strength in bioprocessing and better-than-expected life sciences performance largely offset a lighter-than-normal respiratory season at Cepheid. President and CEO Rainer Blair said the company delivered "better than expected adjusted EPS growth" by "leveraging the Danaher Business System
DHR beats Q1 EPS estimates and lifts 2026 outlook, but revenues miss as Diagnostics lags while bioprocessing strength and Masimo deal shape growth plans.
Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Danaher Corp (NYSE:DHR) on Tuesday reported first-quarter 2026 sales of $5.95 billion, up 3.5% year-over-year, but under the consensus of $5.99 billion. Core revenue increased 0.5% year-over-year.
Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
If biotech funding continues to increase this year, Danaher could benefit.
Danaher (DHR) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $1.88 per share a year ago.
Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit momentum in its Biotechnology and Life Sciences segments.
Life sciences firm Danaher topped first-quarter profit expectations on Tuesday, fueled by strong demand for its bioprocessing tools used in drug manufacturing, lifting shares 2% in premarket trading.
WASHINGTON, April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.
DHR heads into Q1 results with rising bioprocessing demand and steady estimates, but cost pressures and FX headwinds could weigh on performance.
Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Border to Coast Pensions Partnership Ltd lessened its stake in Danaher Corporation (NYSE: DHR) by 41.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 119,536 shares of the conglomerate's stock after selling 84,814 shares during the quarter. Border to Coast
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing BREA, Calif., April 13, 2026 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad availability of a high-throughput host‑response test that helps clinicians differentiate between bacterial and viral infections in approximately 20 minutes.
Dara Capital US Inc. purchased a new position in Danaher Corporation (NYSE: DHR) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,667 shares of the conglomerate's stock, valued at approximately $1,068,000. Danaher makes up 0.9% of
Altfest L J and Co. Inc. lifted its holdings in shares of Danaher Corporation (NYSE: DHR) by 135.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,357 shares of the conglomerate's stock after purchasing an additional 7,677 shares during the quarter. Altfest
Bartlett and CO. Wealth Management LLC lowered its stake in Danaher Corporation (NYSE: DHR) by 7.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 63,440 shares of the conglomerate's stock after selling 4,899 shares during the quarter. Bartlett and CO. Wealth Management LLC's holdings
Douglas Lane and Associates LLC lifted its stake in Danaher Corporation (NYSE: DHR) by 3.5% during the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned 437,475 shares of the conglomerate's stock after buying an additional 14,996 shares during the quarter. Danaher makes up about 1.4% of
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
CCLA Investment Management lessened its stake in shares of Danaher Corporation (NYSE: DHR) by 14.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 622,571 shares of the conglomerate's stock after selling 103,405 shares during the period. Danaher comprises about 2.3% of CCLA Investment Management's portfolio,
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Masimo Corporation (NasdaqGS: MASI) to Danaher Corporation (NYSE: DHR). Under the terms of the proposed transaction, shareholders of Masimo will receive $180.00 in cash for each share of Masimo that they own. KSF is seeking to determine whether this consideration and the process that led to it are ad.
Fulton Breakefield Broenniman LLC lowered its position in Danaher Corporation (NYSE: DHR) by 27.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,301 shares of the conglomerate's stock after selling 18,647 shares during the quarter. Fulton Breakefield Broenniman LLC's holdings
Danaher is an American healthcare company that manufactures and markets products used for advances in biotechnology, life sciences, and diagnostics. Danaher has increased its dividend for 13 consecutive years. And its dividend growth has been nothing short of spectacular. DHR has a strong financial position. Its long-term debt/equity ratio is 0.3, while the interest coverage ratio is 17.
Runnymede Capital Advisors Inc. bought a new position in Danaher Corporation (NYSE: DHR) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 3,658 shares of the conglomerate's stock, valued at approximately $837,000. Several other institutional investors and hedge funds have also recently modified their holdings of
Ascent Group LLC increased its position in Danaher Corporation (NYSE: DHR) by 28.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,723 shares of the conglomerate's stock after acquiring an additional 2,811 shares during the period. Ascent Group LLC's
FNY Investment Advisers LLC grew its holdings in Danaher Corporation (NYSE: DHR) by 16,106.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,700 shares of the conglomerate's stock after acquiring an additional 4,671 shares during the period. FNY Investment
Defender Capital LLC. acquired a new stake in shares of Danaher Corporation (NYSE: DHR) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 156,015 shares of the conglomerate's stock, valued at approximately $35,715,000. Danaher makes up about 11.6% of Defender
First Bank and Trust bought a new position in shares of Danaher Corporation (NYSE: DHR) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,610 shares of the conglomerate's stock, valued at approximately $1,055,000. Other institutional investors and hedge funds also recently
Carderock Capital Management Inc. increased its position in shares of Danaher Corporation (NYSE: DHR) by 15.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 24,465 shares of the conglomerate's stock after buying an additional 3,362 shares during the period.
Danaher (NYSE: DHR - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk. Institutional and Insider Ownership 79.1% of Danaher shares are
WASHINGTON, March 20, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2026 on Tuesday, April 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour.
Coastline Trust Co grew its holdings in Danaher Corporation (NYSE: DHR) by 71.5% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,746 shares of the conglomerate's stock after acquiring an additional 5,312 shares during the quarter. Coastline Trust Co's holdings
CIBC Bancorp USA Inc. purchased a new position in shares of Danaher Corporation (NYSE: DHR) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 88,168 shares of the conglomerate's stock, valued at approximately $17,480,000. Several other large investors also recently modified their holdings of
Danica Pension Livsforsikringsaktieselskab purchased a new stake in shares of Danaher Corporation (NYSE: DHR) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 160,030 shares of the conglomerate's stock, valued at approximately $31,728,000. Several other large investors have also recently
Alliancebernstein L.P. decreased its stake in Danaher Corporation (NYSE: DHR) by 9.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 887,732 shares of the conglomerate's stock after selling 95,655 shares during the period. Alliancebernstein L.P. owned 0.13% of
Bamco Inc. NY lowered its stake in Danaher Corporation (NYSE: DHR) by 36.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 47,329 shares of the conglomerate's stock after selling 26,807 shares during the quarter. Bamco Inc. NY's holdings in Danaher were worth
Bank of Nova Scotia decreased its position in shares of Danaher Corporation (NYSE: DHR) by 54.0% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 211,365 shares of the conglomerate's stock after selling 248,580 shares during the
Banco Bilbao Vizcaya Argentaria S.A. grew its stake in Danaher Corporation (NYSE: DHR) by 63.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,032 shares of the conglomerate's stock after buying an additional 27,834 shares during the quarter. Banco Bilbao Vizcaya Argentaria
